CLPBY Financials: Coloplast A/S AI Analysis



Financials

CLPBY Financial

Coloplast A/S

$6.3

-1.86%

$-0.12

At close: May 08, 16:00:00 GMT-4

$6.3

Post-market: May 08, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$6.42

Open

$6.39

Day's Range

$6.29 - $6.39

52 week range

$6.26 - $11.44

Volume

54.9K

Avg.Volume

659.8K

Dividend yield

EPS (TTM)

0.28

Market Cap

$13.0B

What is Coloplast AS?

Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

CLPBY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	27,891	7,043	6,960	6,958	6,930	7,026
Revenue Growth (YoY)	2%	0%	0%	1%	5%	6%
Cost of Revenue	8,961	2,308	2,198	2,253	2,202	2,276
Gross Profit	18,930	4,735	4,762	4,705	4,728	4,750
Selling, General & Admin	10,440	2,644	2,592	2,578	2,626	2,624
Research & Development	974	247	249	239	239	219
Operating Expenses	11,322	2,885	2,810	2,790	2,837	2,838
Other Non Operating Income (Expenses)	-176	-21	-19	-120	-16	-13
Pretax Income	6,179	1,791	1,555	1,342	1,491	1,769
Income Tax Expense	2,190	394	680	537	579	725
Net Income	3,989	1,397	875	805	912	1,044
Net Income Growth	-18%	34%	-33%	-37%	-27%	-14%
Shares Outstanding (Diluted)	225	225	225.4	225.4	225.4	225.3
Shares Change (YoY)	0%	0%	0%	0%	0%	3%
EPS (Diluted)	17.72	6.2	3.88	3.57	4.04	4.63
EPS Growth	-18%	34%	-33%	-37%	-27%	-16%
Free Cash Flow	5,338	1,819	1,874	1,213	432	1,699
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	67.87%	67.22%	68.41%	67.62%	68.22%	67.6%
Operating Margin	27.27%	26.26%	28.04%	27.52%	27.28%	27.21%
Profit Margin	14.3%	19.83%	12.57%	11.56%	13.16%	14.85%
Free Cash Flow Margin	19.13%	25.82%	26.92%	17.43%	6.23%	24.18%
EBITDA	9,078	2,195	2,390	2,258	2,235	2,240
EBITDA Margin	32.54%	31.16%	34.33%	32.45%	32.25%	31.88%
D&A For EBITDA	1,470	345	438	343	344	328
EBIT	7,608	1,850	1,952	1,915	1,891	1,912
EBIT Margin	27.27%	26.26%	28.04%	27.52%	27.28%	27.21%
Effective Tax Rate	35.44%	21.99%	43.72%	40.01%	38.83%	40.98%

Follow-Up Questions

What are Coloplast A/S's key financial statements?



According to the latest financial statement (Form-10K), Coloplast A/S has a total asset of $0, Net loss of $0

What are the key financial ratios for CLPBY?



Coloplast A/S's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Coloplast A/S's revenue broken down by segment or geography?



Coloplast A/S largest revenue segment is Ostomy Care, at a revenue of 9,897,000,000 in the most earnings release.For geography, European Markets is the primary market for Coloplast A/S, at a revenue of 15,510,000,000.

Is Coloplast A/S profitable?



no, according to the latest financial statements, Coloplast A/S has a net loss of $0

Does Coloplast A/S have any liabilities?



no, Coloplast A/S has liability of 0

How many outstanding shares for Coloplast A/S?



Coloplast A/S has a total outstanding shares of 0

Coloplast A/S (CLPBY) Financial

CLPBY Stock Price Chart